AFP ( Alpha Feto Protein )
Medical information on AFP : |
|
- Evaluation of patients with primary hepatocellular carcinoma.
- An aid in the management of patients with non-seminomatous germ cells tumors.
- Monitoring individuals with hepatic cirrhosis from any etiology for progression to hepatocellular carcinoma.
- As one component in combination with other parameters to evaluate the risk of Trisomy 21(Down syndrome).
|
Anti CCP
Medical Information on Anti-Cyclic Citrullinated Peptide |
|
Anti CCP antibodies are potentially important surrogate markers for diagnosis and prognosis in rheumatoid arthritis (RA), because they:
- are as sensitive as, and more specific than, IgM rheumatoid factors in early and fully established disease. One study using CCP1 assay showed a sensitivity of 55% and a specificity of 97% for RA in early stage of arthritis. J Rheumatology 2002;29:2074-6
- may predict the eventual development into RA when found in undifferentiated arthritis
- are marker of erosive disease in RA
- may be detected in healthy individuals years before onset of clinical RA
- a positive anti-ccp, a negative RF and clinical signs of RA, diagnosis will likely be RA. If the disease is not actively not present at the time, it is probable that it will develop in the future.
- rely more on the symptoms and signs of RA for a diagnosis if the anti-ccp is negative and the RF is positive.
- Autoantibody levels represent one parameter in a multi criterion diagnostic process, encompassing both clinical and laboratory based assessments.
|
Anti-TSH receptor antibodies
Medical Information on Anti-Cyclic Citrullinated Peptide |
|
| Thyrotropin (TSH ) receptor antibodies are a class of thyroid autoantibodies directed against TSH receptor protein, a protein primarily found on thyroid cells. They have a stimulating effect on the synthesis of the liberation of thyroid hormone. |
| Clinical relevance of the Test : |
|
Thyrotropin receptor antibodies are increased in :
1. Graves’ disease
2. Atropic thyroiditis
3. Post partum autoimmune thyroid disease
4. Neonatal Graves’s disease
5. Transient neonatal hypothyroidism
The test may also help distinguish Graves’ disease from hyperthyroidism caused by toxic nodular goiter. Another indication remains the assessment of pregnant women who have Graves’ disease in order to determine the likely risk of neonatal thyrotoxicosis. |